A Canadian startup refuels to take on a rare cardiac condition that many patients don't realize they have
A year and a half ago, a small biotech launched out of Laval, Quebec to one-up beta blockers for the treatment of a rare heart …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
